Laboratory Corporation of America Holdings (LH)
After hours:
| Previous close | 203.26 |
| Open | 204.22 |
| Bid | 81.08 x 800 |
| Ask | 321.68 x 800 |
| Day's range | 200.76 - 204.57 |
| 52-week range | 172.10 - 222.42 |
| Volume | |
| Avg. volume | 790,068 |
| Market cap | 17.813B |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | 19.04 |
| EPS (TTM) | 10.56 |
| Earnings date | 26 Oct 2023 |
| Forward dividend & yield | 2.88 (1.43%) |
| Ex-dividend date | 07 Aug 2023 |
| 1y target est | 247.92 |
PR NewswireLabcorp to Announce Third Quarter Financial Results on October 26, 2023
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2023 before the market opens on Thursday, October 26, 2023. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
ZacksHere's Why Investors Should Retain Labcorp (LH) Stock for Now
Investors are increasingly optimistic about Labcorp (LH) due to its progress in hospital partnerships.
PR NewswireGraves Gilbert, Circuit Clinical, and Labcorp Join Forces to Bring Clinical Trials to Patients across South Central Kentucky
Graves Gilbert, a multispecialty clinic comprised of more than 200 providers representing over 30 medical specialties in Bowling Green, Kentucky, and surrounding counties, is proud to announce a collaboration with Circuit Clinical, an integrated research organization, to bring clinical trials to patients in South Central Kentucky. The partnership supports broader efforts to bring clinical research to community settings, advance medical treatments, and improve equitable healthcare for diverse and
